Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SINOMAB-BIOSCIENCE-LIMITE-103501705/news/SinoMab-BioScience-Limited-Announces-SM03-Completion-of-Enrollment-in-Phase-III-Clinical-Trial-in-C-37180407/?utm_source=whatsapp&utm_medium=social&utm_campaign=share